Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 11Nasopharyngeal Carcinoma 7Melanoma 3Lung Neoplasms 3Esophageal Squamous Cell Carcinoma 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Nasopharyngeal Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Recurrence 1Pleural Effusion, Malignant 1Osteosarcoma 1Neuroblastoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1Advanced Pancreatic Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Cancer 1

Interventions

Bevacizumab 234Fluorouracil 220Oxaliplatin 216Irinotecan 215Leucovorin 199Capecitabine 153Cetuximab 146Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15Biopsy 15apatinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × endostar protein × Clear all
NCT01529164 2013-11-27

Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer

ChineseAMS

Phase 2 Unknown
51 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01832948 2013-04-16

Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00813137 2009-12-08

FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

Simcere Pharmaceutical Co., Ltd

Phase 2 Unknown
120 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡